Answer
Mild impairment may be manageable, but the combination is not recommended in moderate or severe hepatic impairment because of limitations applying to encorafenib.
Sources for this answer
- Mektovi 15 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.